UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

Clinical lung cancer, 2014-09, Vol.15 (5), p.346-355

2014

Volltextzugriff (PDF)

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

Journal of thoracic oncology, 2015-10, Vol.10 (10), p.1437-1443

2015

Volltextzugriff (PDF)

Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5614-5627

2017

Volltextzugriff (PDF)

Successful treatment with avapritinib in patient with mucosal metastatic melanoma

Therapeutic advances in medical oncology, 2020-07, Vol.12

2020

Volltextzugriff (PDF)

Thymic epithelial tumors: From biology to treatment

Cancer treatment reviews, 2020-06, Vol.86, p.102014-102014, Article 102014

2020

Volltextzugriff (PDF)

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2604-2611

2010

Volltextzugriff (PDF)

Stem Cell Transplantation Effectively Occludes Bronchopleural Fistula in an Animal Model

The Annals of thoracic surgery, 2014-02, Vol.97 (2), p.480-483

2014

Volltextzugriff (PDF)

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

The New England journal of medicine, 2014-03, Vol.370 (13), p.1189-1197

2014

Volltextzugriff (PDF)

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

Biomedicines, 2023-02, Vol.11 (3), p.732

2023

Volltextzugriff (PDF)

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Clinical cancer research, 2021-08, Vol.27 (15), p.4311-4324

2021

Volltextzugriff (PDF)

Breast phyllodes tumor: A review of literature and a single center retrospective series analysis

Critical reviews in oncology/hematology, 2013-11, Vol.88 (2), p.427-436

2013

Volltextzugriff (PDF)

High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study

Lung cancer (Amsterdam, Netherlands), 2023-02, Vol.176, p.98-102

2023

Volltextzugriff (PDF)

Prognostic role of lymph node involvement in lung metastasectomy

The Journal of thoracic and cardiovascular surgery, 2007-04, Vol.133 (4), p.967-972

2007

Volltextzugriff (PDF)

Different Response to Immunotherapy According to Melanoma Histologic Subtype

Journal of immunotherapy (1997), 2022-02, Vol.45 (2), p.119-124

2022

Volltextzugriff (PDF)

Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center

European journal of cancer (1990), 2024-01, Vol.196, p.113423-113423, Article 113423

2024

Volltextzugriff (PDF)

Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.

Breast (Edinburgh), 2024-02, Vol.73, p.103672-103672, Article 103672

2024

Volltextzugriff (PDF)

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

Frontiers in immunology, 2024, Vol.15, p.1340979-1340979

2024

Volltextzugriff (PDF)

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib

Journal of clinical oncology, 2011-12, Vol.29 (34), p.e819-e822

2011

Volltextzugriff (PDF)

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E

OncoTargets and therapy, 2014-01, Vol.7, p.697-702

2014

Volltextzugriff (PDF)

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Breast (Edinburgh), 2023-06, Vol.69, p.258-264

2023

Volltextzugriff (PDF)

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3494-3499

2023

Volltextzugriff (PDF)

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer

ESMO open, 2017, Vol.2 (3), p.e000219-e000219, Article e000219

2017

Volltextzugriff (PDF)

Oligometastatic Non–Small Cell Lung Cancer: A Multidisciplinary Approach in the Positron Emission Tomographic Scan Era

The Annals of thoracic surgery, 2007, Vol.83 (1), p.231-234

2007

Volltextzugriff (PDF)

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2015-10, Vol.10 (10), p.1458-1467

2015

Volltextzugriff (PDF)

1 – 25 von 434

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Lancet Oncology

ThemaChemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(346)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(118)
Science & Technology
(118)
Oncology
(101)
Humans
(99)
Female
(57)
Male
(53)
Middle Aged
(49)
Aged
(45)
Humanities And Social Sciences
(37)
Adult
(35)
Lung Neoplasms - Drug Therapy
(35)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(29)
Sociology
(29)
Biological And Medical Sciences
(27)
Lung Neoplasms - Pathology
(26)
Medical Sciences
(26)
Respiratory System
(26)
Treatment Outcome
(22)
Carcinoma, Non-Small-Cell Lung - Pathology
(21)
Tumors
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors

Successful treatment with avapritinib in patient with mucosal metastatic melanoma

Thymic epithelial tumors: From biology to treatment

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Stem Cell Transplantation Effectively Occludes Bronchopleural Fistula in an Animal Model

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Breast phyllodes tumor: A review of literature and a single center retrospective series analysis

High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study

Prognostic role of lymph node involvement in lung metastasectomy

Different Response to Immunotherapy According to Melanoma Histologic Subtype

Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center

Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer

Oligometastatic Non–Small Cell Lung Cancer: A Multidisciplinary Approach in the Positron Emission Tomographic Scan Era

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer

Aktive Filter

Suchergebnisse filtern